Long-term effects of trans fatty acid intake during pregnancy and lactation: Does it have deleterious consequences?

Future Lipidology

Volumn 3, Issue 5, 2008, Pages 489-494

  Herrera, Emilio ^a   Ramos, Maria Pilar ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Adipose tissue; Fetal programming; Insulin resistance; Lactation; Obesity; PAI 1; Pregnancy; Trans fatty acids

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; EDIBLE OIL; INSULIN; TRANS FATTY ACID; VEGETABLE OIL;

ARTICLE; BODY FAT; DIET RESTRICTION; FAT INTAKE; FETUS RISK; FOOD INTAKE; GESTATIONAL AGE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LACTATION; LONG TERM EXPOSURE; LOW BIRTH WEIGHT; MATERNAL NUTRITION; NONHUMAN; OBESITY; PERINATAL DEVELOPMENT; PLACENTAL TRANSFER; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN SECRETION; RISK ASSESSMENT;

RATTUS;

EID: 55849088407     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460875.3.5.489     Document Type: Article

References (56)

1. Pisani LP, Oller do Nascimento CM, Bueno AA et al.: Hydrogenated fat diet intake during pregnancy and lactation modifies the PAI-1 gene expression in white adipose tissue of offspring in adult life. Lipids Health Dis. 7, 13 (2008).
2. Lumey LH, Ravelli AC, Wiessing LG, Koppe JG, Treffers PE, Stem ZA: The Dutch Famine Birth Cohort study: design, validation of exposure, and selected characteristics of subjects after 43 years follow-up. Paediatr. Perinat. Epidemiol. 7, 354-367 (1993).
3. Ravelli AC, van der Meulen JH, Michels RP et al.: Glucose tolerance in adults after prenatal exposure to famine. Lancet 351, 173-177 (1998).
4. Ravelli GP, Stein ZA, Susser MW: Obesity in young men after famine exposure in utero and early infancy. N. Engl. J. Med. 295, 349-353 (1976).
5. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP: Obesity at the age of 50 years in men and women exposed to famine prenatally. Am. J. Clin. Nutr. 70, 811-816 (1999).
6. Ibrahim A, Natrajan S, Ghafoorunissa R: Dietary trans-fatty acids alter adipocyte plasma membrane fatty acid composition and insulin sensitivity in rats. Metabolism 54, 240-246 (2005).
7. Lichtenstein AH, Erkkila AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM: Influence of hydrogenated fat and butter on CVD risk factors: remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis 171, 97-107 (2003).
8. Salmeron J, Hu FB, Manson JE et al.: Dietary fat intake and risk of Type 2 diabetes in women. Am. J. Clin. Nutr. 73, 1019-1026 (2001).
9. Saravanan N, Haseeb A, Ehtesham NZ, Ghafoorunissa: Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur. J. Endocrinol. 153, 159-165 (2005).
10. Mozaffarian D, Pischon T, Hankinson SE et al.: Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 79, 606-612 (2004).
11. Lucas A: Programming by early nutrition: an experimental approach. J. Nutr. 128, 401S-406S (1998).
12. Barker JD: The fetal and infant origins of disease. Eur. J. Clin. Invest. 25, 457-463 (1995).
13. Harder T, Rodekamp E, Schellong K, Dudenhausen JW, Plagemann A: Birth weight and subsequent risk of Type 2 diabetes: a meta-analysis. Am. J. Epidemiol. 165, 849-857 (2007).
14. Lauren L, Jarvelin MR, Elliott P et al.: Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature. Int. J. Epidemiol. 32, 862-876 (2003).
15. Lucas A: Programming by early nutrition in man. Ciba Found. Symp. 156, 38-50; discussion 50-55 (1991).
16. Das NU: Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period? J. Nutr. Biochem. 18, 701-713 (2007).
17. Herrera E: Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur. J. Clin. Nutr. 54, S47-S51 (2000).
18. Herrera E: Implications of dietary fatty acids during pregnancy on placental, fetal and postnatal development - a review. Placenta 23(Suppl. A), S9-S19 (2002).
19. Harding EJ: The nutritional basis of the fetal origins of adult disease. Int. J. Epidemiol. 30, 15-23 (2001).
20. Ford SP, Hess BW, Schwope MM et al.: Maternal undernutrition during early to mid-gestation in the ewe results in altered growth, adiposity, and glucose tolerance in male offspring. J. Anim. Sci. 85, 1285-1294 (2007).
21. Langley SC, Browne RF, Jackson AA: Altered glucose tolerance in rats exposed to maternal low protein diets in utero. Comp. Biochem. Physiol. Physiol. 109, 223-229 (1994).
22. Lorenzo M, Caldes T, Benito M, Medina JM: Lipogenesis in vivo in maternal and foetal tissues during late gestation in the rat. Biochem. J. 198, 425-428 (1981).
23. Neary RH, Kilby MD, Kumpatula P et al.: Fetal and maternal lipoprotein metabolism in human pregnancy. Clin. Sci. (Lond). 88, 311-318 (1995).
24. Vuorio AF, Miettinen TA, Turtola H, Oksanen H, Gylling H: Cholesterol metabolism in normal and heterozygous familial hypercholesterolemic newborns. J. Lab. Clin. Med. 140, 35-42 (2002).
25. Herrera E, Lasuncion MA: Maternal-fetal transfer of lipid metabolites. In: Fetal and Neonatal Physiology. Polin RA, Fox WW, Abman SH (Eds). Saunders, PA, USA 2855-2865 (2004).
26. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H: Maternal lipid metabolism and placental lipid transfer. Horm. Res. 65(Suppl. 3), 59-64 (2006).
27. Napoli C, D'Armiento FP, Mancini FP et al.: Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia - intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100, 2680-2690 (1997).
28. Gerber RT, Holemans K, O'Brien-Coker I et al.: Cholesterol-independent endothelial dysfunction in virgin and pregnant rats fed a diet high in saturated fat. J. Physiol. 517(Pt 2), 607-616 (1999).
29. Khan IY, Dekou V, Douglas G et al.: A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R127-R133 (2005).
30. Siemelink M, Verhoef A, Dormans JA, Span PN, Piersma AH: Dietary fatty acid composition during pregnancy and lactation in the rat programs growth and glucose metabolism in the offspring. Diabetologia 45, 1397-1403 (2002).
31. Herrera E, López-Soldado I, Limones M, Amusquivar E, Ramos MP: Lipid metabolism during the perinatal phase and its implication on postnatal development. Int J. Vitam. Nutr. Res. 76, 216-224 (2006).
32. Ailhaud G, Guesnet P: Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes. Rev. 5, 21-26 (2004).
33. Sugano M, Ikeda I: Metabolic interactions between essential and trans-fatty acids. Curr. Opin. Lipidol. 7, 38-42 (1996).
34. Larque E, Garcia-Ruiz PA, Perez-Llamas F, Zamora S, Gil A: Dietary trans fatty acids alter the compositions of microsomes and mitochondria and the activities of microsome Δ6-fatty acid desaturase and glucose-6-phosphatase in livers of pregnant rats. J. Nutr. 133, 2526-2531 (2003).
35. Das NU: A defect in the activity of Δ6 and Δ5 desaturases maybe a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukot. Essent. Fatty Acids 72, 343-350 (2005).
36. Moore CE, Dhopeshwarkar GA: Placental transport of trans fatty acids in the rat. Lipids 15, 1023-1028 (1980).
37. von Houwelingen AC, Hornstra G: Trans fatty acids in early human development. World Rev. Nutr. Diet. 75, 175-178 (1994).
38. Hornstra G, van Eijsden M, Dirix C, Bonsel G: Trans fatty acids and birth outcome: some first results of the MEFAB and ABCD cohorts. Atheroscler. Suppl. 7, 21-23 (2006).
39. van Eijsden M, Hornstra G, van der Wal MF, Vrijkotte TG, Bonsel GJ: Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am. J. Clin. Nutr. 87, 887-895 (2008).
40. Morrison JA, Glueck CJ, Wang P: Dietary trans fatty acid intake is associated with increased fetal loss. Fertil. Steril. 90(2), 385-390 (2007).
41. Assumpcao RP, Santos FD, Setta CL et al.: Trans fatty acids in maternal diet may impair lipid biosynthesis in mammary gland of lactating rats. Ann. Nutr. Metab. 46, 169-175 (2002).
42. Assumpcao RP, dos Santos FD, de Mattos Machado Andrade P, Barreto GF, das Gracas Tavares do Carmo M: Effect of variation of trans-fatty acid in lactating rats' diet on lipoprotein lipase activity in mammary gland, liver, and adipose tissue. Nutrition 20, 806-811 (2004).
43. Hornstra G: Essential fatty acids in mothers and their neonates. Am. J. Clin. Nutr. 71, 1262S-1269S (2000).
44. Rosen BS, Cook KS, Yaglom J et al.: Adipsin and complement factor activity D: an immune-related defect in obesity. Science 244, 1483-1487 (1989).
45. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-90 (1993).
46. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46, 860-867 (1997).
47. Sawdey MS, Loskutoff DJ: Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-α, and transforming growth factor-β. J. Clin. Invest. 88, 1346-1353 (1991).
48. Xu H, Barnes GT, Yang Q et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resiatance. J. Clin. Invest. 112, 1821-1830 (2003).
49. Silva AP, Guimaraes DE, Mizurini DM et al.: Dietary fatty acids early in life affect lipid metabolism and adiposity in young rats. Lipids 41, 535-541 (2006).
50. Pisani LP, Oyama LM, Buena AA et al.: Hydrogenated fat intake during pregnancy and lactation modifies serum lipid profile and adipokine mRNA in 21-day-old rats. Nutrition 24, 255-261 (2008).
51. Segarra A, Chacon P, Martinez-Eyarre C et al.: Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J. Am. Soc. Nephrol. 12, 1255-1263 (2001).
52. Alessi MC, Juhan-Vague I: PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler. Thromb. Vasc. Biol. 26, 2200-2207 (2006).
53. Shillabeer G, Lau DC: Regulation of new fat cell formation in rats: the role of dietary fats. J. Lipid Res. 35, 592-600 (1994).
54. Das NU: Pathophysiology of metabolic syndrome X and its links to the perinatal period. Nutrition 21, 762-773 (2005).
55. Das NU: Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult diseases. Med. Sci. Monit. 10, HY19-HY25 (2004).
56. Das NU: Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis. 7, 9 (2008).